MUC1 and neoplasm: Within this context, especially mucin-type O-glycan sTn poses a suitable pan-carcinoma glycotarget, given its high, tumor-specific expression on oncoprotein CD44 as well as MUC1, MUC2, MUC5AC, and MUC6 [84].